Hepatic steatosis and patients with inflammatory bowel disease: when transient elastography makes the difference
Recent studies suggest an increased prevalence of hepatic steatosis (HS) in patients with inflammatory bowel disease (IBD). Features such as chronic inflammation, previous surgeries, drug-induced hepatotoxicity, malnutrition, and intestinal dysbiosis seem to be involved in its pathogenesis. Backgrou...
Autor principal: | |
---|---|
Outros Autores: | , , , , , , |
Formato: | article |
Idioma: | eng |
Publicado em: |
2019
|
Assuntos: | |
Texto completo: | http://hdl.handle.net/1822/67209 |
País: | Portugal |
Oai: | oai:repositorium.sdum.uminho.pt:1822/67209 |